ӳ��ý

Skip to main content

Top menu

Careers

Search

Show results from

ӳ��ý
Research
Centers
Education and outreach
News
Careers
Search

Institute Members

Institute Members are faculty members of MIT, Harvard, or a Harvard-affiliated hospital. They are deeply engaged in the intellectual life of ӳ��ý, help set its scientific direction, and serve as mentors across our scientific community. Core Institute Members have their primary laboratories at ӳ��ý.

Meet our Institute Members

ӳ��ý Members

Address

Merkin Building
415 Main St.
Cambridge, MA 02142

Follow Us

Sign up for our newsletter

Name

Did you know?

In March of 2020, ӳ��ý converted a clinical genetics processing lab into a large-scale COVID-19 testing facility in less than two weeks.

We've screened more than 1,275 cancer cell lines as part of the Cancer Dependency Map (DepMap).

ӳ��ý Genomics Platform sequences a whole human genome every four minutes.

More than 11,000 individuals living with cancer in the United States and Canada have partnered with Count Me In to share their experiences and help accelerate cancer research.

The Drug Repurposing Hub is one of the most comprehensive and up-to-date biologically annotated collections of FDA-approved compounds in the world. Researchers anywhere can explore more than 6,000 drugs in the hub and search for possible new uses for them to jump-start new drug discovery.

In 2021, our sustainability efforts sent more than 80 percent of waste from the Genomics Platform to either a recycling facility or to an incineration plant that generates electricity.

Through ӳ��ý's Scientists in the Classroom program, ӳ��ý researchers visit every 8th grade classroom in Cambridge each year to talk about genetics and evolution.

Every summer, 18 high school students spend six weeks at ӳ��ý working side-by-side with mentors on cutting-edge research.

In November 2022, ӳ��ý’s Genomics Platform sequenced its 500,000th whole human genome, a mere four years after sequencing its 100,000th.

By the end of 2022, ӳ��ý’s COVID-19 testing lab had processed more than 37 million tests.

Working with Addgene, ӳ��ý has shared CRISPR genome-editing reagents with researchers at more than 3,200 institutions in 76 countries.

The NeuroGAP-Psychosis project, a collaboration between the Stanley Center for Psychiatric Research and Harvard T.H. Chan School of Public Health to study the genetics of severe mental illness, has recruited more than 42,000 participants in Ethiopia, Kenya, Uganda, and South Africa.

Footer menu

Report a concern
Contact Us
Privacy Policy

© ӳ��ý 2024